Lv1
20 积分 2025-06-09 加入
Astragaloside IV inhibits epithelial-mesenchymal transition and pulmonary fibrosis via lncRNA-ATB/miR-200c/ZEB1 signaling pathway
9个月前
已完结
Astragaloside IV combined with quercetin attenuates silica-induced pulmonary fibrosis by promoting autophagy and suppressing pyroptosis
9个月前
已完结
Astragaloside IV protects against lung injury and pulmonary fibrosis in COPD by targeting GTP-GDP domain of RAS and downregulating the RAS/RAF/FoxO signaling pathway
9个月前
已完结
Artemisinin-hydroxychloroquine combination from traditional antimalarial medicine attenuates pulmonary fibrosis via PI3K/AKT/GSK3β-mediated inhibition of epithelial-mesenchymal transition
10个月前
已完结
Mechanism study of the effects of astragaloside IV and quercetin on idiopathic pulmonary fibrosis
10个月前
已完结
Pathological features of connective tissue disease‐associated interstitial lung disease in transbronchial cryobiopsies
10个月前
已完结
Small Airway Reduction and Fibrosis Is an Early Pathologic Feature of Idiopathic Pulmonary Fibrosis
10个月前
已完结
Nanotechnology for diagnosis and therapy of idiopathic pulmonary fibrosis: Recent advances and future perspectives
10个月前
已完结
Advances in Novel Therapeutics for Idiopathic Pulmonary Fibrosis
10个月前
已完结
Idiopathic pulmonary fibrosis
10个月前
已完结
皖公网安备34019202002308
